Jacobs Levy Equity Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Jacobs Levy Equity Management’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-113,436	Closed	-$1.38M	–	1111
2020 Q3	$1.38M	Sell	113,436 -10,542	-9%	-$141K	0.01%	593
2020 Q2	$1.43M	Buy	123,978 +17,788	+17%	+$245K	0.02%	592
2020 Q1	$1.46M	Buy	106,190 +722	+0.7%	+$8.54K	0.02%	544
2019 Q4	$622K	Buy	105,468 +54,312	+106%	+$295K	0.01%	757
2019 Q3	$271K	Buy	51,156 +31,049	+154%	+$206K	﹤0.01%	796
2019 Q2	$155K	Sell	20,107 -54,763	-73%	-$834K	﹤0.01%	897
2019 Q1	$1.49M	Buy	74,870 +29,040	+63%	+$506K	0.02%	573
2018 Q4	$605K	Sell	45,830 -2,030	-4%	-$40.6K	0.01%	705
2018 Q3	$1.76M	Buy	47,860 +8,424	+21%	+$270K	0.03%	544
2018 Q2	$1.38M	Buy	+39,436	New	+$1.51M	0.02%	586
2018 Q1	–	Sell	-11,130	Closed	-$417K	–	1084
2017 Q4	$417K	Buy	11,130 +7,620	+217%	+$333K	0.01%	787
2017 Q3	$187K	Buy	3,510 +470	+15%	+$27.9K	﹤0.01%	876
2017 Q2	$173K	Buy	+3,040	New	+$153K	﹤0.01%	860
2016 Q4	–	Sell	-3,142	Closed	-$195K	–	1080
2016 Q3	$195K	Sell	3,142 -5,058	-62%	-$358K	﹤0.01%	914
2016 Q2	$464K	Sell	8,200 -1,424	-15%	-$86.5K	0.01%	777
2016 Q1	$616K	Buy	+9,624	New	+$778K	0.01%	684

Other funds holding KDNY

ALSV

ATP Life Science Ventures New York $898M AUM 84.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management's KDNY Position: Q4 2020 in Review

Jacobs Levy Equity Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q4 2020, closing a stake of 113,436 shares — an estimated $1.38M sold.

Jacobs Levy Equity Management first reported a position in KDNY in Q1 2016 and held it in 16 quarters. The position peaked at $1.76M in Q3 2018. 77 funds tracked by Wall St. Rank hold KDNY as of Q4 2020.

Jacobs Levy Equity Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Jacobs Levy Equity Management sold 113,436 Chinook Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $1.38M.
Jacobs Levy Equity Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q1 2016 and held it in 16 quarters.
Jacobs Levy Equity Management's Chinook Therapeutics, Inc. Common Stock position peaked at $1.76M in Q3 2018.
77 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q4 2020.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2020, filed 16 Feb 2021.